Fletcher Aaron G.L.
SEC-identified person · CIK 1789490 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Cognition Therapeutics INC CGTX | Director | filed 2021 - 2026 |
| Actuate Therapeutics, INC. ACTU | Director | filed 2024 - 2026 |
| Lantern Pharma Inc. LTRN | Officer | filed 2020 - 2025 |
| In8BIO, INC. [INAB | Director | filed 2021 - 2025 |
| Azitra, Inc. AZTR | Officer | filed 2023 - 2023 |
| Cue Biopharma, Inc. CUE | Director | filed 2019 - 2023 |
| TFF Pharmaceuticals, Inc. TFFP | Director | filed 2019 - 2022 |
| SWK Holdings Corp swkh | Director | filed 2019 - 2022 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.